Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: Role of enhanced oxidative stress

Atherosclerosis

Volumn 138, Issue 1, 1998, Pages 65-77

  Galle, Jan ^a   Schneider, Reinhard ^a   Winner, Beate ^a   Lehmann Bodem, Cordula ^a   Schinzel, Reinhard ^b   Münch, Gerald ^b   Conzelmann, Ernst ^b   Wanner, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Diabetes mellitus; EDRF; Hypercholesterolemia; Hypertension; LDL; Nitric oxide; Vascular disease

Indexed keywords

LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE;

ARTICLE; BLOOD VESSEL TONE; DIABETES MELLITUS; DISEASE ASSOCIATION; GLYCATION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0032076715     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00005-7     Document Type: Article

References (61)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373.
2. Inagami T., Naruse M., Hoover R. Endothelium as an endocrine organ. Ann Rev Physiol. 57:1995;171.
3. Loscalzo J. Nitric oxide and vascular disease. N Engl J Med. 333:1995;251.
4. Drexler H., Zeiher A.M. Endothelial function in human coronary arteries in vivo - focus on hypercholesterolemia. Hypertension. 18:1991;90.
5. Zeiher A.M., Drexler H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 92:1993;652.
6. Cohen R.A. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 87(Suppl. 5):1993;V67.
7. Galle J., Bengen J., Schollmeyer P., Wanner C. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein (a) - Role of oxygen-derived radicals. Circulation. 92:1995;1582.
8. Galle J., Mülsch A., Busse R., Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler Thromb. 11:1991;198.
9. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature. 344:1990;160.
10. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries - role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 83:1991;2012.
11. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 86:1990;75.
12. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witzum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 84:1989;1086.
13. Chin J.H., Azhar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 89:1992;10.
14. Galle J., Bauersachs J., Busse R., Bassenge E. Inhibition of cyclic AMP-mediated and cyclic GMP-mediated dilations in isolated arteries by oxidized low density lipoproteins. Arterioscler Thromb. 12:1992;180.
15. Galle J., Bassenge E., Busse R. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res. 66:1990;1287.
16. - and renin release in juxtaglomerular cells. Kidney Int. 51:1997;253.
17. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol. 250:1986;H822.
18. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546.
19. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med. 16:1994;383.
20. Ceriello A., Dello Russo P., Amstad P., Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture - Evidence linking hyperglycemia and oxidative stress. Diabetes. 45:1996;471.
21. Kashiwagi A., Asahina T., Nishio Y., Ikebuchi M., Tanaka Y., Kikkawa R., Shigeta Y. Glycation, oxidative stress, and scavenger activity glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes. 45(Suppl. 3):1996;S84.
22. Taus M., Ferretti G., Curatola G., Dousset N., Solèra M.L., Valdiguie P. Lower susceptibility of low density lipoprotein to in vitro oxidation in diabetic patients. Biochem Int. 28:1992;835.
23. Mazière C., Auclair M., Rose-Robert F., Leflon P., Mazière J.C. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation. FEBS Lett. 363:1995;277.
24. Kawamura M., Heinecke J.W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest. 94:1994;771.
25. Bowie A., Owens D., Collins P., Johnson A., Tomkin G.H. Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient. Atherosclerosis. 102:1993;63.
26. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 263:1992;H321.
27. Ohishi K., Carmines P.K. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol. 5:1995;1559.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with phenol reagent. J Biol Chem. 193:1951;265.
29. Makino K., Furbee J.W. Jr., Scanu A.M., Fless G.M. Effect of glycation on the properties of lipoprotein(a). Arterioscler Thromb. 15:1995;385.
30. Münch G., Keis R., Wessels A., Riederer P., Bahner U., Heidland A., Niwa T., Lemke H.-D., Schinzel R. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem. 35:1997;669.
31. Nguyenkhoa T., Nguyen N.T., Zingraff J., Jungers P., Descampslatscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:1996;1304.
32. Means GE, Feeney RE. Chemical Modification of Proteins. San Francisco, CA: Holden-Day, 1971;217.
33. Esterbauer H., Striegel G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm. 6:1989;67.
34. Steinbrecher U.P., Witztum J.L., Parthasarathy S., Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7:1987;135.
35. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226:1957;497.
36. Galle J., Schini V., Stunz P., Wanner C., Schollmeyer P. Interleukin-1β induces the formation of nitric oxide in isolated juxtaglomerular cells: influence on renin secretion. Nephrol Dial Transplant. 10:1995;191.
37. Bucala R., Vlassara H. Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis. 26:1995;875.
38. Esterbauer H., Gebicki J., Puhl H., Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med. 13:1992;341.
39. Freeman J.E., Kuo W.Y., Drenger B., Barnett T.N., Levine M.A., Flavahan N.A. Analysis of lysophosphatidylcholine-induced endothelial dysfunction. J Cardiovasc Pharmacol. 28:1996;345.
40. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524.
41. Lüscher T.F. The endothelium and cardiovascular disease - A complex relation. N Engl J Med. 330:1994;1081.
42. Flavahan N.A. Atherosclerosis or lipoprotein-induced endothelial dysfunction-potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 85:1992;1927.
43. Plane F., Bruckdorfer K.R., Kerr P., Steuer A., Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol. 105:1992;216.
44. Marin J., Rodriguez-Martinez M.A. Nitric oxide, oxygen-derived free radicals and vascular endothelium. J Auton Pharmacol. 15:1995;279.
45. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis. 23(Suppl. 1):1993;118.
46. White C.R., Brock T.A., Chang L.-Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A., Tarpey M.M. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 91:1994;1044.
47. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510.
48. Calver A., Collier J., Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 90:1992;2548.
49. Bohlen H.G., Lash J.M. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol. 265:1993;H219.
50. Clarkson P., Celermajer D.S., Donald A.E., Sampson M., Sorensen K.E., Adams M., Yue D.K., Betteridge D.J., Deanfield J.E. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. JACC. 28:1996;573.
51. Lyons T.J. Glycation and oxidation: A role in the pathogenesis of atherosclerosis. Am J Cardiol. 71:1993;26B.
52. O'Brien R., Timmins K. The role of oxidation and glycation in the pathogenesis of diabetic atherosclerosis. Trends Endocrinol Metabol. 5:1994;329.
53. Hunt J.V., Bottoms M.A., Clare K., Skamarauskas J.T., Mitchinson M.J. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: Possible implications for diabetic atherosclerosis. Biochem J. 300:1994;243.
54. Tsai E.C., Hirsch I.B., Brunzell J.D., Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes. 43:1994;1010.
55. Wolff S.P., Jiang Z.Y., Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med. 10:1991;339.
56. Ichikawa I., Kiyama S., Yoshioka T. Renal antioxidant enzymes: their regulation and function. Kidney Int. 45:1994;1.
57. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA. 82:1985;3000.
58. Yokoyama M., Hirata K., Miyake R., Akita H., Ishikawa Y., Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 168:1990;301.
59. Esterbauer H., Jürgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 28:1987;495.
60. Ohara Y., Peterson T.E., Zheng B., Kuo J.F., Harrison D.G. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 14:1994;1007.
61. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141.